{"related:G_x_ki7INbYJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5":[{"title":"Systemic therapy for renal cell carcinoma","url":"https://www.sciencedirect.com/science/article/pii/S0022534705678895","authors":["RJ Motzer","RJ Motzer P Russo"],"year":2000,"numCitations":773,"citationUrl":"http://scholar.google.com/scholar?cites=13129620391020461083&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:G_x_ki7INbYJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13129620391020461083&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Elsevier","p":1,"exp":1596876833505},{"title":"Cytokine therapy in renal cell cancer","url":"https://www.sciencedirect.com/science/article/pii/S1078143900000685","authors":["J Vuky","J Vuky RJ Motzer"],"year":2000,"numCitations":35,"citationUrl":"http://scholar.google.com/scholar?cites=7944744925228486072&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:uM1Um2pnQW4J:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7944744925228486072&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Elsevier"},{"title":"Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer","url":"https://ascopubs.org/doi/abs/10.1200/jco.1999.17.9.2859","authors":["S Pyrhönen","S Pyrhönen E Salminen","S Pyrhönen E Salminen M Ruutu…"],"year":1999,"numCitations":538,"citationUrl":"http://scholar.google.com/scholar?cites=3794296768673334536&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:CMUv3c4MqDQJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3794296768673334536&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"ascopubs.org"},{"title":"Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJM199804303381805","authors":["S Negrier","S Negrier B Escudier","S Negrier B Escudier C Lasset…"],"year":1998,"numCitations":1090,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJM199804303381805","citationUrl":"http://scholar.google.com/scholar?cites=13125871935387966934&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:1p0RPPt2KLYJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13125871935387966934&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc"},{"title":"Chemotherapy for advanced renal-cell carcinoma: 1983-1993","url":"https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3501764","authors":["A Yagoda","A Yagoda B Abi"],"year":1995,"numCitations":504,"citationUrl":"http://scholar.google.com/scholar?cites=6933375749475115533&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:DaLFcYJMOGAJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6933375749475115533&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"pascal-francis.inist.fr"},{"title":"Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma","url":"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.965.6583&rep=rep1&type=pdf","authors":["RJ Motzer","RJ Motzer M Mazumdar","RJ Motzer M Mazumdar J Bacik","RJ Motzer M Mazumdar J Bacik W Berg…"],"year":1999,"numCitations":1851,"pdf":"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.965.6583&rep=rep1&type=pdf","citationUrl":"http://scholar.google.com/scholar?cites=16620025474542165120&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:gFwHyBwxpuYJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16620025474542165120&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Citeseer"},{"title":"Renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJM199609193351207","authors":["RJ Motzer","RJ Motzer NH Bander","RJ Motzer NH Bander DM Nanus"],"year":1996,"numCitations":2067,"citationUrl":"http://scholar.google.com/scholar?cites=13833377568196553472&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:AGs2HJsH-r8J:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13833377568196553472&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc"},{"title":"Renal cell carcinoma: management of advanced disease","url":"https://www.auajournals.org/doi/abs/10.1016/S0022-5347%2801%2961897-4","authors":["RA FIGLIN"],"year":1999,"numCitations":353,"citationUrl":"http://scholar.google.com/scholar?cites=17260112227918205690&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:-tJwkJ88iO8J:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17260112227918205690&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"auajournals.org"},{"title":"Chemotherapy for renal cell carcinoma.","url":"https://www.ncbi.nlm.nih.gov/pubmed/10768596","authors":["RJ Amato"],"year":2000,"numCitations":274,"citationUrl":"http://scholar.google.com/scholar?cites=2924771152048731118&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:7rMs393fligJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2924771152048731118&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"ncbi.nlm.nih.gov"},{"title":"Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma","url":"https://ascopubs.org/doi/abs/10.1200/JCO.2000.18.16.2972","authors":["RJ Motzer","RJ Motzer BA Murphy","RJ Motzer BA Murphy J Bacik","RJ Motzer BA Murphy J Bacik LH Schwartz…"],"year":2000,"numCitations":311,"citationUrl":"http://scholar.google.com/scholar?cites=15770354014330237639&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:xzJPzmuN29oJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15770354014330237639&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"ascopubs.org"}]}